Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.56
(-0.47%)
CNY 8.56
(-0.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 149.69 Million CNY | -29.82% |
| 2022 | 213.29 Million CNY | 227.03% |
| 2021 | 65.22 Million CNY | 36.36% |
| 2020 | 47.83 Million CNY | 136.49% |
| 2019 | -131.07 Million CNY | 20.71% |
| 2018 | -165.31 Million CNY | -124.27% |
| 2017 | -73.71 Million CNY | -11.32% |
| 2016 | -66.21 Million CNY | -69.3% |
| 2015 | -39.11 Million CNY | -132.63% |
| 2014 | -16.81 Million CNY | -164.28% |
| 2013 | 26.15 Million CNY | 274.1% |
| 2012 | 6.99 Million CNY | -89.29% |
| 2011 | 65.28 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 177.51 Million CNY | 18.58% |
| 2024 Q3 | 103.39 Million CNY | -83.17% |
| 2024 Q2 | 207.56 Million CNY | 16.93% |
| 2023 Q4 | 149.69 Million CNY | -25.69% |
| 2023 FY | 149.69 Million CNY | -29.82% |
| 2023 Q3 | 201.43 Million CNY | -7.25% |
| 2023 Q1 | 198.92 Million CNY | -6.74% |
| 2023 Q2 | 217.18 Million CNY | 9.18% |
| 2022 Q4 | 213.29 Million CNY | -0.8% |
| 2022 Q1 | 119.4 Million CNY | 83.07% |
| 2022 Q2 | 202.24 Million CNY | 69.38% |
| 2022 FY | 213.29 Million CNY | 227.03% |
| 2022 Q3 | 215.02 Million CNY | 6.32% |
| 2021 Q3 | 50.4 Million CNY | 4.18% |
| 2021 FY | 65.22 Million CNY | 36.36% |
| 2021 Q1 | 43.01 Million CNY | -10.07% |
| 2021 Q2 | 48.38 Million CNY | 12.47% |
| 2021 Q4 | 65.22 Million CNY | 29.4% |
| 2020 FY | 47.83 Million CNY | 136.49% |
| 2020 Q1 | -111.68 Million CNY | 14.8% |
| 2020 Q2 | 78.84 Million CNY | 170.6% |
| 2020 Q3 | 87.78 Million CNY | 11.33% |
| 2020 Q4 | 47.83 Million CNY | -45.51% |
| 2019 FY | -131.07 Million CNY | 20.71% |
| 2019 Q2 | -130.93 Million CNY | 16.1% |
| 2019 Q1 | -156.06 Million CNY | 9.15% |
| 2019 Q3 | -165.13 Million CNY | -26.11% |
| 2019 Q4 | -131.07 Million CNY | 20.62% |
| 2018 Q1 | -68.27 Million CNY | 7.37% |
| 2018 FY | -165.31 Million CNY | -124.27% |
| 2018 Q4 | -171.78 Million CNY | 24.84% |
| 2018 Q3 | -228.55 Million CNY | -207.32% |
| 2018 Q2 | -74.36 Million CNY | -8.92% |
| 2017 Q3 | -322.19 Million CNY | -3.03% |
| 2017 FY | -73.71 Million CNY | -11.32% |
| 2017 Q4 | -73.71 Million CNY | 77.12% |
| 2017 Q1 | -343.57 Million CNY | -418.87% |
| 2017 Q2 | -312.7 Million CNY | 8.98% |
| 2016 Q2 | -28.77 Million CNY | -144.89% |
| 2016 FY | -66.21 Million CNY | -69.3% |
| 2016 Q4 | -66.21 Million CNY | 0.0% |
| 2016 Q1 | 64.11 Million CNY | 0.0% |
| 2015 FY | -39.11 Million CNY | -132.63% |
| 2014 Q1 | 17.92 Million CNY | 0.0% |
| 2014 Q2 | 17.92 Million CNY | 0.0% |
| 2014 Q4 | -16.81 Million CNY | 0.0% |
| 2014 FY | -16.81 Million CNY | -164.28% |
| 2013 FY | 26.15 Million CNY | 274.1% |
| 2012 FY | 6.99 Million CNY | -89.29% |
| 2011 FY | 65.28 Million CNY | 0.0% |